Last reviewed · How we verify
methyl donor
At a glance
| Generic name | methyl donor |
|---|---|
| Also known as | Vitamin B6, Vitamin B12, Folic Acid, Placebo |
| Sponsor | Harvard School of Public Health (HSPH) |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- HeartPhone Cancer Survivors Trial 2019 (PHASE1, PHASE2)
- Vitamin Mix (B6, B9, B12, And Choline) For Glaucoma Patients (NA)
- Methyl-donor Nutrient Supplementation and Methylation Profile in Lupus Patients With Obesity (NA)
- The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation
- Muscadine Plus (MPX) In Men With Prostate Cancer (PHASE3)
- Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients (PHASE4)
- Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression (NA)
- The Effect of Sevoflurane and Desflurane on Clara Cell Protein on the Lung (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- methyl donor CI brief — competitive landscape report
- methyl donor updates RSS · CI watch RSS
- Harvard School of Public Health (HSPH) portfolio CI